Close Menu

NEW YORK (GenomeWeb) – CooperSurgical is exiting its genetic carrier screening and noninvasive prenatal testing business, the firm said in a regulatory filing on Friday.

CooperGenomics, a unit of CooperSurgical, itself part of the Cooper Companies, had been offering a carrier screening test called CarrierMap, which tested for more than 300 genetic conditions, as well as an NIPT called ChromoMap, which tested for fetal trisomies 21, 18, and 13 and, optionally, a number of sex chromosome aneuploidies and microdeletions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Jul
23
Sponsored by
Roche

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.